Setting new standards in information exchange for the pharmaceutical and biotech industry
Clinical Trial Collaborations: What Needs to Change Now to Prepare for the Future of the Clinical Research Enterprise
February 16, 2016
Clinical Trial Collaborations focuses on the future of clinical collaborations, research and outsourcing
BOSTON–(BUSINESS WIRE)–Clinical Trial Collaborations, presented by CenterWatch and The Conference Forum, is focused on finding strategic solutions in clinical outsourcing to drive more efficient R&D operations. Impactful insights on the current clinical trials environment will be presented as we ask the big questions on what needs to change now to prepare for the future demands of science, patient needs, new technologies and access to data as well as the changing landscape of R&D infrastructure in both the pharmaceutical and biotech industries. An impressive speaking faculty will share powerful ideas and challenges for R&D operations, CRO and site executives to find new ways to collaborate today and in the next several years.
Co-chaired by Ken Getz, Director, Sponsored Research Programs Tufts CSDD, the program opens with a keynote on, “How the Drug Development Landscape is Changing and the Impact on R&D Operations.” Robert M. Califf, MD, MACC, Deputy Commissioner for Medical Products and Tobacco, FDA, is a confirmed keynote speaker who will present on the FDA 2016 goals and challenges. Quintiles’ CEO, Tom Pike, will provide insights and advice to pharma on addressing global R&D operation realities and how sponsors can better leverage their CRO. Komathi Stem, Strategic Innovation Leader, Genentech/Roche will address the call for greater collaborations between clinical research and clinical care.
The Boston Marriott Cambridge Hotel, in the heart of Kendall Square, is hosting this one-of-a-kind strategic level clinical outsourcing event on March 21-22, 2016.